The present disclosure provides a compound having the structure of Formula (I): X-(Y)n-Z, wherein X is a
drug comprising an anticancer agent; Y is a
cleavable linker selected from esters, ethers, carbamates, amides, ketones, aldehydes, carboxylates, peroxides, anhydrides, amidines, hydrazones, imines, imides, azides, cyanates, nitriles, thiols, sulfides, sulfoxides, sulfones, thiocyanates, thials, thioesters, phosphonic acids, phosphodiesters, boronic acids, and silyl ethers; and Z is a
carborane isomer comprising ortho-, meta-, or para-
carborane; or a pharmaceutically acceptable salt or solvate thereof. The disclosure also provides methods of treating
cancer using the compound and pharmaceutical compositions comprising the compound and a pharmaceutically acceptable
excipient.